Published in Lancet on February 23, 1979
Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol Cell Biol (1995) 3.02
Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology (1997) 2.77
Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol (1994) 2.00
Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol (2001) 1.97
Long-term results of growth hormone treatment in France in children of short stature: population, register based study. BMJ (1997) 1.81
Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment. J Clin Endocrinol Metab (1997) 1.76
Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells. J Cell Biol (1996) 1.73
Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. J Biol Chem (1997) 1.52
Prevention of fatty streak formation of 17beta-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation (1997) 1.50
Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation (2001) 1.50
Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome. N Engl J Med (1992) 1.45
Fou rire prodromique heralding a left internal carotid artery occlusion. Stroke (1997) 1.44
Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology (2001) 1.42
Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int J Cancer (1993) 1.42
[Post-phlebitic leg ulcers and XYY karyotype: fibrinolysis and androgenic function tests. Apropos of 3 cases]. Ann Dermatol Venereol (1987) 1.41
Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation (1998) 1.40
Angiographic architecture of intracranial vascular malformations and fistulas--pretherapeutic aspects. Neurosurg Rev (1986) 1.40
[Acute hepatopathy compatible with Reye's syndrome in 3 children treated by chemotherapy]. Arch Pediatr (1994) 1.39
The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci U S A (2002) 1.38
Within-session and between-session reproducibility of cerebral sensorimotor activation: a test--retest effect evidenced with functional magnetic resonance imaging. J Cereb Blood Flow Metab (2001) 1.35
Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ Res (2002) 1.29
The accessory middle cerebral artery (AMCA). Diagnostic and therapeutic consequences. Anat Clin (1984) 1.25
Neural substrate for the effects of passive training on sensorimotor cortical representation: a study with functional magnetic resonance imaging in healthy subjects. J Cereb Blood Flow Metab (2000) 1.24
True and false fenestration of the vertebral artery. J Neuroradiol (1980) 1.21
New ways of initiating translation in eukaryotes. Mol Cell Biol (2001) 1.20
Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice. Atherosclerosis (2001) 1.17
Comparison of three ELISA tests for seroepidemiology of bovine fascioliosis. Vet Parasitol (1998) 1.17
Potential oncogenic effects of basic fibroblast growth factor requires cooperation between CUG and AUG-initiated forms. Cell Regul (1991) 1.17
Arterial anomalies at the base of the skull. Neuroradiology (1977) 1.16
Mental development in congenital hypothyroidism after neonatal screening. Arch Dis Child (1987) 1.15
Preoperative embolization of intracranial meningiomas. AJNR Am J Neuroradiol (1986) 1.13
The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr (1972) 1.12
Absence of neutralizing effect of antisera to the unique structural region of human chorionic gonadotropin. J Clin Endocrinol Metab (1974) 1.10
17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (1997) 1.10
Mucoceles of the paranasal sinuses: uncommon location. J Laryngol Otol (1998) 1.10
Relative value of computed tomography and hypocycloidal tomography in the diagnosis of pituitary microadenoma. A radio-surgical correlative study. Neuroradiology (1981) 1.07
Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium. J Clin Endocrinol Metab (1978) 1.06
Physicochemical and genetic evidence for specific antiestrogen binding sites. Proc Natl Acad Sci U S A (1983) 1.06
Possible role of protein phosphorylation in the mitogenic effect of high density lipoproteins on cultured vascular endothelial cells. J Biol Chem (1986) 1.06
Detection of superoxide anion released extracellularly by endothelial cells using cytochrome c reduction, ESR, fluorescence and lucigenin-enhanced chemiluminescence techniques. Free Radic Biol Med (2000) 1.06
Alternative initiation of translation accounts for a 67/45 kDa dimorphism of the human estrogen receptor ERalpha. Biochem Biophys Res Commun (1999) 1.05
Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci U S A (1996) 1.04
Posterior extradural migration of extruded thoracic and lumbar disc fragments: role of MRI. Neuroradiology (1999) 1.03
Intracranial dural arteriovenous fistulae with perimedullary venous drainage. Anatomical, clinical and therapeutic considerations. Neuroradiology (1999) 1.03
NF-kappa B activation by tumor necrosis factor and interleukin-1. Cold Spring Harb Symp Quant Biol (1999) 1.03
Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women. Int J Obes (1991) 1.03
Specific antisera produced by direct immunization with slices of polyacrylamide gel containing small amounts of protein. J Immunol Methods (1982) 1.01
Allopatric combination of Fasciola hepatica and Lymnaea truncatula is more efficient than sympatric ones. Int J Parasitol (2000) 1.00
Cavernous hemangiomas of the orbit: MR imaging. J Neuroradiol (1999) 0.99
Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line. Cancer Res (1995) 0.98
Measurement of plasma aldosterone by radioimmunoassay. J Clin Endocrinol Metab (1970) 0.98
Usefulness of motor functional MRI correlated to cortical mapping in Rolandic low-grade astrocytomas. Acta Neurochir (Wien) (1999) 0.97
[Dilatation of the vein of Galen. Anatomoclinical forms and endovascular treatment apropos of 14 cases explored and/or treated between 1983 and 1986]. Neurochirurgie (1987) 0.97
Obesity and postmenopausal bone loss: the influence of obesity on vertebral density and bone turnover in postmenopausal women. Bone (1987) 0.97
Plasma aldosterone concentration at delivery and during the newborn period. J Clin Invest (1972) 0.97
Chemical and enzymatic characterization of the collagenase from the insect Hypoderma lineatum. Eur J Biochem (1979) 0.96
Alteration of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatous rabbit aorta. Cardiovasc Res (2001) 0.96
Comparative study of biosynthetic human growth hormone immunogenicity in growth hormone deficient children. Horm Res (1991) 0.96
Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors. Invest Radiol (1999) 0.96
Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events. Cancer Res (1987) 0.95
Diagnosis of C.S.F. rhinorrhoea by computerised cisternography using metrizamide. Lancet (1977) 0.95
Role of fibroblast growth factor-2 isoforms in the effect of estradiol on endothelial cell migration and proliferation. Circ Res (2004) 0.94
Transplacental passage and fetal secretion of aldosterone. J Clin Invest (1970) 0.94
Bone mineral density and thyroid hormone therapy. Clin Endocrinol (Oxf) (1990) 0.94
Evidence of a role of adrogens in follicular maturation. Endocrinology (1975) 0.93
Autocrine regulation of bovine retinal capillary endothelial cell (BREC) proliferation by BREC-derived basic fibroblast growth factor. Exp Eye Res (1989) 0.93
Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children. Horm Res (2000) 0.93
Cerebral thrombophlebitis in three patients with probable multiple sclerosis. Role of lumbar puncture or intravenous corticosteroid treatment. Cerebrovasc Dis (1999) 0.92
Computed tomography in diabetes insipidus. J Comput Assist Tomogr (1979) 0.92
Guidelines for neonatal screening programmes for congenital hypothyroidism. Working group on congenital hypothyroidism of the European Society for Paediatric Endocrinology. Eur J Pediatr (1993) 0.91
Inflammatory myofibroblastic tumour of the spinal cord: case report and review of the literature. Neuroradiology (2003) 0.91
Fasciola hepatica: influence of gender and liver biotransformations on flukicide treatment efficacy of rats infested and cured with either clorsulon/ivermectin or triclabendazole. Exp Parasitol (2000) 0.91
Pure motor hemiplegia: CT study of 30 cases. Stroke (1982) 0.91
[Shapiro's syndrome. Recurrent spontaneous hypothermia with hypoplasia of the corpus callosum]. Pediatrie (1975) 0.90
Cavernous hemangioma of the intracranial optic pathways: CT and MRI. J Comput Assist Tomogr (1999) 0.90
Bilateral wallerian degeneration of the middle cerebellar peduncles due to unilateral pontine infarction. J Neuroradiol (2006) 0.89
Estrogens and atherosclerosis. Eur J Endocrinol (2004) 0.89
The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr Res (1973) 0.89
Measurement of plasma 25-hydroxycholecalciferol in man. Eur J Clin Invest (1972) 0.89
[The surface of epiphyses of the knee: index of the duration of neonatal hypothyroidism]. Arch Fr Pediatr (1984) 0.89
Magnetic resonance imaging and axial involvement in spondylarthropathies. Delineation of the spinal entheses. Rev Rhum Engl Ed (1997) 0.88
[Pituitary stalk transection syndrome]. Arch Pediatr (1998) 0.88
Interaction of estrogen and gonadotrophins on follicular atresia. Endocrinology (1975) 0.88
Phorbol esters induce both intracellular translocation and down-regulation of protein kinase C in MCF-7 cells. Biochem Biophys Res Commun (1986) 0.88
Immunological responses of rabbits artificially infested with the cattle grubs Hypoderma bovis (L.) and H. Lineatum (De Vill.) (Diptera: Oestridae). Int J Parasitol (1973) 0.88
Vasculoprotective effects of oestrogens. Clin Exp Pharmacol Physiol (2001) 0.87
[Multiple chondroma affecting the spine: spondylo-enchondroplasia and other forms (author's transl)]. J Radiol (1981) 0.87
Clinical use of the long acting somatostatin analogue octreotide in pediatrics. Eur J Pediatr (1994) 0.87
[Arteries of the human spinal dura mater]. Acta Radiol Diagn (Stockh) (1972) 0.87
[Neonatal screening of hypothyroidism in France. One million quantitative analyses and psycho-motor development of 20 detected cases]. J Genet Hum (1981) 0.87
[Treatment of carotid cavernous fistulas by venous approach. Report of one case]. J Neuroradiol (1980) 0.87
Cerebrospinal fluid rhinorrhea: evaluation with metrizamide cisternography. AJR Am J Roentgenol (1982) 0.87
Loss of atheroprotective effect of estradiol in immunodeficient mice. Endocrinology (2000) 0.87
[Hypoplasia of cartilage and hair with combined immune deficiency]. Ann Pediatr (Paris) (1989) 0.86
Transplacental passage of dexamethasone in sheep. J Endocrinol (1972) 0.86
Intramuscular injections of slow-release lanreotide (BIM 23014) in acromegalic patients previously treated with continuous subcutaneous infusion of octreotide (SMS 201-995). Eur J Endocrinol (1995) 0.86